{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:03:10Z","timestamp":1780131790233,"version":"3.54.0"},"reference-count":62,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The pathophysiology of development, growth, and rupture of arteriovenous malformations (AVMs) is only partially understood. However, inflammation is known to play an essential role in many vascular diseases. This feasibility study was conducted to investigate the expression of enzymes (cyclooxygenase 2 [COX-2] and NLRP3 [NOD-, LRR-, and pyrin domain\u2013containing protein 3]) in the AVM nidus that are essential in their inflammatory pathways and to explore how these influence the pathophysiology of AVMs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>The study group comprised 21 patients with partially thrombosed AVMs. The cohort included 8 ruptured and 13 unruptured AVMs, which had all been treated microsurgically. The formaldehyde-fixed and paraffin-embedded samples were immunohistochemically stained with a monoclonal antibody against COX-2 and NLRP3 (COX-2 clone: CX-294; NLRP3: ab214185). The authors correlated MRI and clinical data with immunohistochemistry, using the Trainable Weka Segmentation algorithm for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      The median AVM volume was 2240 mm\n                      <jats:sup>3<\/jats:sup>\n                      . The proportion of NLRP3-positive cells was significantly higher (26.23%\u201383.95%), compared to COX-2 positive cells (0.25%\u201314.94%, p &lt; 0.0001). Ruptured AVMs had no higher expression of NLRP3 (p = 0.39) or COX-2 (p = 0.44), compared to nonruptured AVMs. Moreover, no patient characteristics could be reported that showed significant correlations to the enzyme expression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>NLRP3 consistently showed an approximately 10-fold higher expression level than COX-2, making the inflammatory process in AVMs appear to be mainly associated with ischemic (NLRP3)\u2013driven rather than with mechanical (COX-2)\u2013driven inflammatory pathways. No direct associations between NLRP3 and COX-2 expression and radiological, standard histopathological, or patient characteristics were found in this cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2022.4.focus2210","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T07:36:45Z","timestamp":1656661005000},"page":"E3","source":"Crossref","is-referenced-by-count":6,"title":["Ischemia-induced inflammation in arteriovenous malformations"],"prefix":"10.3171","volume":"53","author":[{"given":"Jan","family":"Rodemerk","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin Darkwah","family":"Oppong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Junker","sequence":"additional","affiliation":[{"name":"Institute for Neuropathology, University Hospital Essen, University Duisburg-Essen; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"Deuschl","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forsting","sequence":"additional","affiliation":[{"name":"Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Dammann","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Uerschels","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramazan","family":"Jabbarli","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Sure","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten H.","family":"Wrede","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital Essen, University Duisburg-Essen;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"19","key":"b1","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1056\/NEJMra1607407","article-title":"Arteriovenous malformations of the brain","volume":"376","author":"Solomon RA","year":"2017","unstructured":"Solomon RA, Connolly ES Jr. Arteriovenous malformations of the brain. N Engl J Med. 2017;376(19):1859\u20131866.10.1056\/NEJMra160740714552705"},{"issue":"3","key":"b2","series-title":"Eur Radiol","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00330-015-3875-0","article-title":"Non-enhanced MR imaging of cerebral arteriovenous malformations at 7 Tesla","volume":"26","author":"Wrede KH","year":"2016","unstructured":"Wrede KH, Dammann P, Johst S,  Non-enhanced MR imaging of cerebral arteriovenous malformations at 7 Tesla. Eur Radiol. 2016;26(3):829\u2013839.10.1007\/s00330-015-3875-014552705"},{"issue":"7","key":"b3","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/neurintsurg-2016-012485","article-title":"Multicenter assessment of morbidity associated with cerebral arteriovenous malformation hemorrhages","volume":"9","author":"Fukuda K","year":"2017","unstructured":"Fukuda K, Majumdar M, Masoud H,  Multicenter assessment of morbidity associated with cerebral arteriovenous malformation hemorrhages. J Neurointerv Surg. 2017;9(7):664\u2013668.10.1136\/neurintsurg-2016-012485"},{"issue":"5","key":"b4","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.STR.0000217970.18319.7d","article-title":"Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation","volume":"37","author":"Choi JH","year":"2006","unstructured":"Choi JH, Mast H, Sciacca RR,  Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37(5):1243\u20131247.10.1161\/01.STR.0000217970.18319.7d"},{"issue":"Pt2","key":"b5","series-title":"Brain","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/brain\/awn318","article-title":"Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies","volume":"132","author":"van Beijnum J","year":"2009","unstructured":"van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJ, Al-Shahi Salman R. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2009;132(Pt2):537\u2013543.10.1093\/brain\/awn318"},{"issue":"3","key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3171\/jns.1988.68.3.0352","article-title":"The natural history of unruptured intracranial arteriovenous malformations","volume":"68","author":"Brown RD Jr","year":"1988","unstructured":"Brown RD Jr, Wiebers DO, Forbes G,  The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1988;68(3):352\u2013357.10.3171\/jns.1988.68.3.0352"},{"issue":"5","key":"b7","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1227\/00006123-198411000-00003","article-title":"Natural history of arteriovenous malformations of the brain: a clinical study","volume":"15","author":"Fults D","year":"1984","unstructured":"Fults D, Kelly DL Jr. Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery. 1984;15(5):658\u2013662.10.1227\/00006123-198411000-00003"},{"issue":"1","key":"b8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3171\/2015.9.JNS151311","article-title":"Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort","volume":"126","author":"Starke RM","year":"2017","unstructured":"Starke RM, Kano H, Ding D,  Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort. J Neurosurg. 2017;126(1):36\u201344.10.3171\/2015.9.JNS151311"},{"issue":"5","key":"b9","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1227\/NEU.0000000000000919","article-title":"Seizure outcomes in patients with surgically treated cerebral arteriovenous malformations","volume":"77","author":"von der Brelie C","year":"2015","unstructured":"von der Brelie C, Simon M, Esche J, Schramm J, Bostr\u00f6m A. Seizure outcomes in patients with surgically treated cerebral arteriovenous malformations. Neurosurgery. 2015;77(5):762\u2013768.10.1227\/NEU.0000000000000919"},{"issue":"5","key":"b10","series-title":"Transl Stroke Res","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12975-014-0351-0","article-title":"Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations","volume":"5","author":"Rutledge WC","year":"2014","unstructured":"Rutledge WC, Ko NU, Lawton MT, Kim H. Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res. 2014;5(5):538\u2013542.10.1007\/s12975-014-0351-0"},{"issue":"7","key":"b11","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00701-020-04391-w","article-title":"Histopathology of brain AVMs part I: microhemorrhages and changes in the nidal vessels","volume":"162","author":"Jarvelin P","year":"2020","unstructured":"Jarvelin P, Wright R, Pekonen H, Keranen S, Rauramaa T, Frosen J. Histopathology of brain AVMs part I: microhemorrhages and changes in the nidal vessels. Acta Neurochir (Wien). 2020;162(7):1735\u20131740.10.1007\/s00701-020-04391-w"},{"issue":"6","key":"b12","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1227\/01.NEU.0000312339.62339.FC","article-title":"Evidence of inflammatory cell involvement in brain arteriovenous malformations","volume":"62","author":"Chen Y","year":"2008","unstructured":"Chen Y, Zhu W, Bollen AW,  Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery. 2008;62(6):1340\u20131350.10.1227\/01.NEU.0000312339.62339.FC"},{"key":"b13","series-title":"Nat Rev Dis Primers","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/nrdp.2015.8","article-title":"Brain arteriovenous malformations","volume":"1","author":"Lawton MT","year":"2015","unstructured":"Lawton MT, Rutledge WC, Kim H,  Brain arteriovenous malformations. Nat Rev Dis Primers. 2015;1:15008.10.1038\/nrdp.2015.8"},{"issue":"10","key":"b14","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1161\/01.STR.0000141932.44613.b1","article-title":"Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations","volume":"35","author":"Pawlikowska L","year":"2004","unstructured":"Pawlikowska L, Tran MN, Achrol AS,  Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke. 2004;35(10):2294\u20132300.10.1161\/01.STR.0000141932.44613.b1"},{"issue":"2","key":"b15","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000185609","article-title":"Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation","volume":"27","author":"Kim H","year":"2009","unstructured":"Kim H, Hysi PG, Pawlikowska L,  Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis. 2009;27(2):176\u2013182.10.1159\/000185609"},{"issue":"8","key":"b16","series-title":"Nat Rev Immunol","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson KV","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u2013489.10.1038\/s41577-019-0165-0"},{"issue":"2)(suppl","key":"b17","series-title":"Int J Immunopathol Pharmacol","first-page":"59","article-title":"Transcriptional regulation of cyclo-oxygenase expression: three pillars of control","volume":"16","author":"Ramsay RG","year":"2003","unstructured":"Ramsay RG, Ciznadija D, Vanevski M, Mantamadiotis T. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int J Immunopathol Pharmacol. 2003;16(2)(suppl):59\u201367."},{"issue":"5B","key":"b18","series-title":"Am J Med","doi-asserted-by":"publisher","first-page":"37S","DOI":"10.1016\/S0002-9343(99)00115-1","article-title":"Role and regulation of cyclooxygenase-2 during inflammation","volume":"106","author":"Simon LS","year":"1999","unstructured":"Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 1999;106(5B):37S\u201342S.10.1016\/S0002-9343(99)00115-1"},{"issue":"8","key":"b19","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/STROKEAHA.120.030590","article-title":"Pathophysiology of intracranial aneurysms: COX-2 expression, iron deposition in aneurysm wall, and correlation with magnetic resonance imaging","volume":"51","author":"Rodemerk J","year":"2020","unstructured":"Rodemerk J, Junker A, Chen B,  Pathophysiology of intracranial aneurysms: COX-2 expression, iron deposition in aneurysm wall, and correlation with magnetic resonance imaging. Stroke. 2020;51(8):2505\u20132513.10.1161\/STROKEAHA.120.030590"},{"issue":"3","key":"b20","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bpa.12828","article-title":"In the wall lies the truth: a systematic review of diagnostic markers in intracranial aneurysms","volume":"30","author":"Jabbarli R","year":"2020","unstructured":"Jabbarli R, Rauschenbach L, Dinger TF,  In the wall lies the truth: a systematic review of diagnostic markers in intracranial aneurysms. Brain Pathol. 2020;30(3):437\u2013445.10.1111\/bpa.12828"},{"issue":"2","key":"b21","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bpa.12476","article-title":"A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?","volume":"27","author":"Barrington J","year":"2017","unstructured":"Barrington J, Lemarchand E, Allan SM. A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?. Brain Pathol. 2017;27(2):205\u2013212.10.1111\/bpa.12476"},{"key":"b22","series-title":"Life Sci","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.lfs.2019.04.031","article-title":"NLRP3 inflammasome activates interleukin-23\/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice","volume":"227","author":"Wang H","year":"2019","unstructured":"Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G. NLRP3 inflammasome activates interleukin-23\/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. Life Sci. 2019;227:101\u2013113.10.1016\/j.lfs.2019.04.031"},{"issue":"3","key":"b23","series-title":"Am J Physiol Heart Circ Physiol","doi-asserted-by":"publisher","first-page":"H485","DOI":"10.1152\/ajpheart.00035.2016","article-title":"Fluid shear stress induces upregulation of COX-2 and PGI2 release in endothelial cells via a pathway involving PECAM-1, PI3K, FAK, and p38","volume":"312","author":"Russell-Puleri S","year":"2017","unstructured":"Russell-Puleri S, Dela Paz NG, Adams D,  Fluid shear stress induces upregulation of COX-2 and PGI2 release in endothelial cells via a pathway involving PECAM-1, PI3K, FAK, and p38. Am J Physiol Heart Circ Physiol. 2017;312(3):H485\u2013H500.10.1152\/ajpheart.00035.2016"},{"issue":"9","key":"b24","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s00701-021-04895-z","article-title":"Cyclo-oxygenase 2, a putative mediator of vessel remodeling, is expressed in the brain AVM vessels and associates with inflammation","volume":"163","author":"Ker\u00e4nen S","year":"2021","unstructured":"Ker\u00e4nen S, Suutarinen S, Mallick R,  Cyclo-oxygenase 2, a putative mediator of vessel remodeling, is expressed in the brain AVM vessels and associates with inflammation. Acta Neurochir (Wien). 2021;163(9):2503\u20132514.10.1007\/s00701-021-04895-z"},{"issue":"4","key":"b25","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jcp.24815","article-title":"Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1\u03b2 production","volume":"230","author":"Hua KF","year":"2015","unstructured":"Hua KF, Chou JC, Ka SM,  Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1\u03b2 production. J Cell Physiol. 2015;230(4):863\u2013874.10.1002\/jcp.24815"},{"issue":"11","key":"b26","series-title":"J Immunol","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.4049\/jimmunol.1401343","article-title":"Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages","volume":"194","author":"Sokolowska M","year":"2015","unstructured":"Sokolowska M, Chen LY, Liu Y,  Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J Immunol. 2015;194(11):5472\u20135487.10.4049\/jimmunol.1401343"},{"issue":"2","key":"b27","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/jcbfm.2014.179","article-title":"Biology of cerebral arteriovenous malformations with a focus on inflammation","volume":"35","author":"Mouchtouris N","year":"2015","unstructured":"Mouchtouris N, Jabbour PM, Starke RM,  Biology of cerebral arteriovenous malformations with a focus on inflammation. J Cereb Blood Flow Metab. 2015;35(2):167\u2013175.10.1038\/jcbfm.2014.179"},{"issue":"3","key":"b28","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/2014.7.FOCUS14214","article-title":"Molecular and cellular biology of cerebral arteriovenous malformations: a review of current concepts and future trends in treatment","volume":"37","author":"Rangel-Castilla L","year":"2014","unstructured":"Rangel-Castilla L, Russin JJ, Martinez-Del-Campo E, Soriano-Baron H, Spetzler RF, Nakaji P. Molecular and cellular biology of cerebral arteriovenous malformations: a review of current concepts and future trends in treatment. Neurosurg Focus. 2014;37(3):E1.10.3171\/2014.7.FOCUS14214"},{"issue":"20","key":"b29","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1212\/WNL.0000000000010968","article-title":"Brain arteriovenous malformations: a review of natural history, pathobiology, and interventions","volume":"95","author":"Chen CJ","year":"2020","unstructured":"Chen CJ, Ding D, Derdeyn CP,  Brain arteriovenous malformations: a review of natural history, pathobiology, and interventions. Neurology. 2020;95(20):917\u2013927.10.1212\/WNL.0000000000010968"},{"issue":"7","key":"b30","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00701-020-04328-3","article-title":"Histopathology of brain AVMs part II: inflammation in arteriovenous malformation of the brain","volume":"162","author":"Wright R","year":"2020","unstructured":"Wright R, Jarvelin P, Pekonen H, Keranen S, Rauramaa T, Frosen J. Histopathology of brain AVMs part II: inflammation in arteriovenous malformation of the brain. Acta Neurochir (Wien). 2020;162(7):1741\u20131747.10.1007\/s00701-020-04328-3"},{"issue":"9917","key":"b31","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(13)62302-8","article-title":"Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial","volume":"383","author":"Mohr JP","year":"2014","unstructured":"Mohr JP, Parides MK, Stapf C,  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614\u2013621.10.1016\/S0140-6736(13)62302-8"},{"issue":"19","key":"b1","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1056\/NEJMra1607407","article-title":"Arteriovenous malformations of the brain","volume":"376","author":"Solomon RA","year":"2017","unstructured":"Solomon RA, Connolly ES Jr. Arteriovenous malformations of the brain. N Engl J Med. 2017;376(19):1859\u20131866.10.1056\/NEJMra1607407"},{"issue":"3","key":"b2","series-title":"Eur Radiol","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00330-015-3875-0","article-title":"Non-enhanced MR imaging of cerebral arteriovenous malformations at 7 Tesla","volume":"26","author":"Wrede KH","year":"2016","unstructured":"Wrede KH, Dammann P, Johst S,  Non-enhanced MR imaging of cerebral arteriovenous malformations at 7 Tesla. Eur Radiol. 2016;26(3):829\u2013839.10.1007\/s00330-015-3875-0"},{"issue":"7","key":"b3","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/neurintsurg-2016-012485","article-title":"Multicenter assessment of morbidity associated with cerebral arteriovenous malformation hemorrhages","volume":"9","author":"Fukuda K","year":"2017","unstructured":"Fukuda K, Majumdar M, Masoud H,  Multicenter assessment of morbidity associated with cerebral arteriovenous malformation hemorrhages. J Neurointerv Surg. 2017;9(7):664\u2013668.10.1136\/neurintsurg-2016-012485"},{"issue":"5","key":"b4","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1161\/01.STR.0000217970.18319.7d","article-title":"Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation","volume":"37","author":"Choi JH","year":"2006","unstructured":"Choi JH, Mast H, Sciacca RR,  Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke. 2006;37(5):1243\u20131247.10.1161\/01.STR.0000217970.18319.7d"},{"issue":"Pt2","key":"b5","series-title":"Brain","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/brain\/awn318","article-title":"Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies","volume":"132","author":"van Beijnum J","year":"2009","unstructured":"van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJ, Al-Shahi Salman R. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2009;132(Pt2):537\u2013543.10.1093\/brain\/awn318"},{"issue":"3","key":"b6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3171\/jns.1988.68.3.0352","article-title":"The natural history of unruptured intracranial arteriovenous malformations","volume":"68","author":"Brown RD Jr","year":"1988","unstructured":"Brown RD Jr, Wiebers DO, Forbes G,  The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg. 1988;68(3):352\u2013357.10.3171\/jns.1988.68.3.0352"},{"issue":"5","key":"b7","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1227\/00006123-198411000-00003","article-title":"Natural history of arteriovenous malformations of the brain: a clinical study","volume":"15","author":"Fults D","year":"1984","unstructured":"Fults D, Kelly DL Jr. Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery. 1984;15(5):658\u2013662.10.1227\/00006123-198411000-00003"},{"issue":"1","key":"b8","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3171\/2015.9.JNS151311","article-title":"Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort","volume":"126","author":"Starke RM","year":"2017","unstructured":"Starke RM, Kano H, Ding D,  Stereotactic radiosurgery for cerebral arteriovenous malformations: evaluation of long-term outcomes in a multicenter cohort. J Neurosurg. 2017;126(1):36\u201344.10.3171\/2015.9.JNS151311"},{"issue":"5","key":"b9","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1227\/NEU.0000000000000919","article-title":"Seizure outcomes in patients with surgically treated cerebral arteriovenous malformations","volume":"77","author":"von der Brelie C","year":"2015","unstructured":"von der Brelie C, Simon M, Esche J, Schramm J, Bostr\u00f6m A. Seizure outcomes in patients with surgically treated cerebral arteriovenous malformations. Neurosurgery. 2015;77(5):762\u2013768.10.1227\/NEU.0000000000000919"},{"issue":"5","key":"b10","series-title":"Transl Stroke Res","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s12975-014-0351-0","article-title":"Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations","volume":"5","author":"Rutledge WC","year":"2014","unstructured":"Rutledge WC, Ko NU, Lawton MT, Kim H. Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res. 2014;5(5):538\u2013542.10.1007\/s12975-014-0351-0"},{"issue":"7","key":"b11","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s00701-020-04391-w","article-title":"Histopathology of brain AVMs part I: microhemorrhages and changes in the nidal vessels","volume":"162","author":"Jarvelin P","year":"2020","unstructured":"Jarvelin P, Wright R, Pekonen H, Keranen S, Rauramaa T, Frosen J. Histopathology of brain AVMs part I: microhemorrhages and changes in the nidal vessels. Acta Neurochir (Wien). 2020;162(7):1735\u20131740.10.1007\/s00701-020-04391-w"},{"issue":"6","key":"b12","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1227\/01.NEU.0000312339.62339.FC","article-title":"Evidence of inflammatory cell involvement in brain arteriovenous malformations","volume":"62","author":"Chen Y","year":"2008","unstructured":"Chen Y, Zhu W, Bollen AW,  Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery. 2008;62(6):1340\u20131350.10.1227\/01.NEU.0000312339.62339.FC"},{"key":"b13","series-title":"Nat Rev Dis Primers","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/nrdp.2015.8","article-title":"Brain arteriovenous malformations","volume":"1","author":"Lawton MT","year":"2015","unstructured":"Lawton MT, Rutledge WC, Kim H,  Brain arteriovenous malformations. Nat Rev Dis Primers. 2015;1:15008.10.1038\/nrdp.2015.8"},{"issue":"10","key":"b14","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1161\/01.STR.0000141932.44613.b1","article-title":"Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations","volume":"35","author":"Pawlikowska L","year":"2004","unstructured":"Pawlikowska L, Tran MN, Achrol AS,  Polymorphisms in genes involved in inflammatory and angiogenic pathways and the risk of hemorrhagic presentation of brain arteriovenous malformations. Stroke. 2004;35(10):2294\u20132300.10.1161\/01.STR.0000141932.44613.b1"},{"issue":"2","key":"b15","series-title":"Cerebrovasc Dis","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000185609","article-title":"Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation","volume":"27","author":"Kim H","year":"2009","unstructured":"Kim H, Hysi PG, Pawlikowska L,  Common variants in interleukin-1-Beta gene are associated with intracranial hemorrhage and susceptibility to brain arteriovenous malformation. Cerebrovasc Dis. 2009;27(2):176\u2013182.10.1159\/000185609"},{"issue":"8","key":"b16","series-title":"Nat Rev Immunol","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson KV","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477\u2013489.10.1038\/s41577-019-0165-0"},{"issue":"2)(suppl","key":"b17","series-title":"Int J Immunopathol Pharmacol","first-page":"59","article-title":"Transcriptional regulation of cyclo-oxygenase expression: three pillars of control","volume":"16","author":"Ramsay RG","year":"2003","unstructured":"Ramsay RG, Ciznadija D, Vanevski M, Mantamadiotis T. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control. Int J Immunopathol Pharmacol. 2003;16(2)(suppl):59\u201367."},{"issue":"5B","key":"b18","series-title":"Am J Med","doi-asserted-by":"publisher","first-page":"37S","DOI":"10.1016\/S0002-9343(99)00115-1","article-title":"Role and regulation of cyclooxygenase-2 during inflammation","volume":"106","author":"Simon LS","year":"1999","unstructured":"Simon LS. Role and regulation of cyclooxygenase-2 during inflammation. Am J Med. 1999;106(5B):37S\u201342S.10.1016\/S0002-9343(99)00115-1"},{"issue":"8","key":"b19","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/STROKEAHA.120.030590","article-title":"Pathophysiology of intracranial aneurysms: COX-2 expression, iron deposition in aneurysm wall, and correlation with magnetic resonance imaging","volume":"51","author":"Rodemerk J","year":"2020","unstructured":"Rodemerk J, Junker A, Chen B,  Pathophysiology of intracranial aneurysms: COX-2 expression, iron deposition in aneurysm wall, and correlation with magnetic resonance imaging. Stroke. 2020;51(8):2505\u20132513.10.1161\/STROKEAHA.120.030590"},{"issue":"3","key":"b20","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/bpa.12828","article-title":"In the wall lies the truth: a systematic review of diagnostic markers in intracranial aneurysms","volume":"30","author":"Jabbarli R","year":"2020","unstructured":"Jabbarli R, Rauschenbach L, Dinger TF,  In the wall lies the truth: a systematic review of diagnostic markers in intracranial aneurysms. Brain Pathol. 2020;30(3):437\u2013445.10.1111\/bpa.12828"},{"issue":"2","key":"b21","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bpa.12476","article-title":"A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?","volume":"27","author":"Barrington J","year":"2017","unstructured":"Barrington J, Lemarchand E, Allan SM. A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?. Brain Pathol. 2017;27(2):205\u2013212.10.1111\/bpa.12476"},{"key":"b22","series-title":"Life Sci","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.lfs.2019.04.031","article-title":"NLRP3 inflammasome activates interleukin-23\/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice","volume":"227","author":"Wang H","year":"2019","unstructured":"Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G. NLRP3 inflammasome activates interleukin-23\/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice. Life Sci. 2019;227:101\u2013113.10.1016\/j.lfs.2019.04.031"},{"issue":"3","key":"b23","series-title":"Am J Physiol Heart Circ Physiol","doi-asserted-by":"publisher","first-page":"H485","DOI":"10.1152\/ajpheart.00035.2016","article-title":"Fluid shear stress induces upregulation of COX-2 and PGI2 release in endothelial cells via a pathway involving PECAM-1, PI3K, FAK, and p38","volume":"312","author":"Russell-Puleri S","year":"2017","unstructured":"Russell-Puleri S, Dela Paz NG, Adams D,  Fluid shear stress induces upregulation of COX-2 and PGI2 release in endothelial cells via a pathway involving PECAM-1, PI3K, FAK, and p38. Am J Physiol Heart Circ Physiol. 2017;312(3):H485\u2013H500.10.1152\/ajpheart.00035.2016"},{"issue":"9","key":"b24","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1007\/s00701-021-04895-z","article-title":"Cyclo-oxygenase 2, a putative mediator of vessel remodeling, is expressed in the brain AVM vessels and associates with inflammation","volume":"163","author":"Ker\u00e4nen S","year":"2021","unstructured":"Ker\u00e4nen S, Suutarinen S, Mallick R,  Cyclo-oxygenase 2, a putative mediator of vessel remodeling, is expressed in the brain AVM vessels and associates with inflammation. Acta Neurochir (Wien). 2021;163(9):2503\u20132514.10.1007\/s00701-021-04895-z"},{"issue":"4","key":"b25","series-title":"J Cell Physiol","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jcp.24815","article-title":"Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1\u03b2 production","volume":"230","author":"Hua KF","year":"2015","unstructured":"Hua KF, Chou JC, Ka SM,  Cyclooxygenase-2 regulates NLRP3 inflammasome-derived IL-1\u03b2 production. J Cell Physiol. 2015;230(4):863\u2013874.10.1002\/jcp.24815"},{"issue":"11","key":"b26","series-title":"J Immunol","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.4049\/jimmunol.1401343","article-title":"Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages","volume":"194","author":"Sokolowska M","year":"2015","unstructured":"Sokolowska M, Chen LY, Liu Y,  Prostaglandin E2 inhibits NLRP3 inflammasome activation through EP4 receptor and intracellular cyclic AMP in human macrophages. J Immunol. 2015;194(11):5472\u20135487.10.4049\/jimmunol.1401343"},{"issue":"2","key":"b27","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/jcbfm.2014.179","article-title":"Biology of cerebral arteriovenous malformations with a focus on inflammation","volume":"35","author":"Mouchtouris N","year":"2015","unstructured":"Mouchtouris N, Jabbour PM, Starke RM,  Biology of cerebral arteriovenous malformations with a focus on inflammation. J Cereb Blood Flow Metab. 2015;35(2):167\u2013175.10.1038\/jcbfm.2014.179"},{"issue":"3","key":"b28","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.3171\/2014.7.FOCUS14214","article-title":"Molecular and cellular biology of cerebral arteriovenous malformations: a review of current concepts and future trends in treatment","volume":"37","author":"Rangel-Castilla L","year":"2014","unstructured":"Rangel-Castilla L, Russin JJ, Martinez-Del-Campo E, Soriano-Baron H, Spetzler RF, Nakaji P. Molecular and cellular biology of cerebral arteriovenous malformations: a review of current concepts and future trends in treatment. Neurosurg Focus. 2014;37(3):E1.10.3171\/2014.7.FOCUS14214"},{"issue":"20","key":"b29","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1212\/WNL.0000000000010968","article-title":"Brain arteriovenous malformations: a review of natural history, pathobiology, and interventions","volume":"95","author":"Chen CJ","year":"2020","unstructured":"Chen CJ, Ding D, Derdeyn CP,  Brain arteriovenous malformations: a review of natural history, pathobiology, and interventions. Neurology. 2020;95(20):917\u2013927.10.1212\/WNL.0000000000010968"},{"issue":"7","key":"b30","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00701-020-04328-3","article-title":"Histopathology of brain AVMs part II: inflammation in arteriovenous malformation of the brain","volume":"162","author":"Wright R","year":"2020","unstructured":"Wright R, Jarvelin P, Pekonen H, Keranen S, Rauramaa T, Frosen J. Histopathology of brain AVMs part II: inflammation in arteriovenous malformation of the brain. Acta Neurochir (Wien). 2020;162(7):1741\u20131747.10.1007\/s00701-020-04328-3"},{"issue":"9917","key":"b31","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(13)62302-8","article-title":"Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial","volume":"383","author":"Mohr JP","year":"2014","unstructured":"Mohr JP, Parides MK, Stapf C,  Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614\u2013621.10.1016\/S0140-6736(13)62302-8"}],"container-title":["Neurosurgical Focus"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/53\/1\/article-pE3.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/53\/1\/article-pE3.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/neurosurg-focus\/53\/1\/article-pE3.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T08:27:24Z","timestamp":1780129644000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/neurosurg-focus\/53\/1\/article-pE3.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":62,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2022.4.focus2210","relation":{},"ISSN":["1092-0684"],"issn-type":[{"value":"1092-0684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}